We would love to hear your thoughts about our site and services, please take our survey here.
Sorry Thorn because you are not invested did you not get invited to the recent Q&A presentation. Everything is going to plan and they expect results mid year as they can do “parallel studies instead of Sequential” try harder idiot. 🤣🤣
Does that normally happen in pharmaceutical takeover deals, come on windy do some research on how they normally go based on oncology platform technology, before you ask me some hypothetical BS micro question that won’t happen. 🥱🤣👍
We are fully funded already for a genuine inflection point, unfortunately it may seem boring 🥱. However we actually don’t need to raise cash at the moment, best getting more data in first for deals or integrating the full DX business build it up and look at potential spin off when it’s established and cash generating. Loads of future options available, Avacta now have the time to see which are most suitable for stakeholder/shareholder value. The share price and sentiment will turn eventually just need to wait it out or take advantage of this discount.
Back with the Agenda Thorn so transparent…. Timelines slipping? please provide evidence? As I have said many a time, the FDA doesn’t care about share price. 50p or 300p irrelevant, FDA approval will be the official catalyst for Avacta (that’s the investment case), it always has been. We are fully funded, full steam ahead with brilliant data. Don’t mix up short term games based on min dilution, with long term value drivers like FDA approval.
2W trial is full steam ahead, clinical results should be released before the next bond conversion is due, well at least some will be announced imo. Don’t agree with the statement as I have already said (unprofessional and pointless however it does show they know Shareholders are pi55ed off) I do expect some news to get sentiment turning in the near future, even if it is partial results as mentioned earlier.
If HC haven’t forward sold, it might not be in their best interests to sell this cache, they have essentially bagged a 16% discount from the oversubscribed original institutional placing at 50p which was also at a 34% discount, that’s a pretty solid foundation when this short clears and sentiment inevitably turns. 🤔💯
that statement means sweet fa was pointless and unprofessional. logically if they get a huge deal in place the conversion would likely have been paid in cash anyways for future qtrs. if they don’t get a huge deal in the conversion will be paid in shares 🙄. all that statement did was try be diplomatic (agree good word) to the angry shareholder groups that obviously emailed him saying pay this time in cash for sentiment reasons. it has done the opposite folk are even more 😡. it matters not longterm though the fda don’t care about the bond, highly entertaining regardless people losing their ****.
You would be extremely naive to think, Avacta wouldn’t listen to them if they say had decided to forward sell this bunch and would have preferred it in shares this quarter instead of cash. Communication is two ways in business. Of course it’s Avacta’s choice at the end of the day. However a couple of emails back and forth go a long way.
Paying the bond in Cash on this occasion while tempting, would have been a trap imo.
1. It sets an expectation and precedent for future quarters.
2. They have a guaranteed cash runaway to see us through the next 24 months. That’s something you don’t want to be messing with.
3. HC might have asked them for shares on this occasion instead of cash. Communication will be frequent.
4. The reason we raised cash in the first place is to negotiate better deals. See above. 👆
Don’t agree with the note in the RNS about future cash payments being possible, that seems to be buckling under pressure from the shareholder groups that are complaining. Would have preferred they stayed silent, seems a little unprofessional.
Although strategy now seems, get the deals in place then pay whatever left in cash. Seems decent and solid enough for the longterm.
Not reminding anyone, they did an article and the price surged from I think 100 to 285 give or take very quickly. My point still stands. Once mainstream media are given the green light to discuss this cancer treatment and the patients involved, hopefully many success stories, the sentiment will turn instantly. Thorn, Avacta announcing real life patient success stories on sky news would certainly not suit your agenda of driving the price down. 🤣🤣👍
“IMO probably untrue”
You did see what happened when the huff post did an article on Avacta? cancer is an extremely hot topic with the British people at the moment with Royal family etc. Any positive media campaign would have a significant impact on sentiment here imo. As I said they have more important things to be getting on with though.
“AVCT is not under any radar”
Totally agree within the niche investment community. However Avacta hasn’t approached MSM yet. I wonder what would be the impact on sentiment and short term price action if they did an interview with sky news explaining some of the positive case studies. People are very much in the dark, about this company and its potential. Avacta could easily solve sentiment overnight by doing a media campaign, however I feel they have more important things to do at the moment. I would keep that in mind though…. Media coverage will eventually happen.
windy not getting into this but you focus on micro bs hypothetical scenarios, forgetting that we are fully funded awaiting more confirmation of the science. (this is a pharma company it is all about the science). let’s have another conversation when the 2w results get published mid year if you are still around and not pestering some other bb pretending to be a hero with no agenda. in the meantime enjoy getting your posts deleted and totally ignored or ****ged off here. 🤘👋
You are trying to drive the share price down🤣💯 You admitted on several occasions are not invested currently. Why are you here otherwise? The agenda is so 🙄🙄 even wanting some HC calculations at 20-10p. Come on..🤣🤣👍